Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google. Opens in new tab
bullish
Akeso Biopharma Inc
Watchlist
Akesobio (康方生物) IPO: Expect near Zero Allocation
Equity Capital Markets
668 Views
14 Apr 2020 05:47
Akesobio launched book building to raise up to USD 333 million to list in Hong Kong. In our previous note, we discussed that the company features...
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 4-minute read)
Related Insights
More »
Loading
Trending Collections
More »
Japan
Index Rebalance
India
Equity Bottom-Up
Sell / Short Ideas
Event-Driven
Philippines
South Korea
Topix Inclusion
Singapore REITs
Trending Insights
More »
GMO Internet (4784) - Shares Appear Manipulated/Squeezed (Again), but ParentCo MUST SELL
ASX200 Index AdHoc Rebalance Preview: Potential Replacement for Spartan Resources (SPR AU)
Mandatory Cancellation of Existing Treasury Shares: A Historic Stock Market Event in the Making
Merger Arb Mondays (14 Jul) - Shibaura, Topcon, Nissin, OneConnect, Insignia, PointsBet, ENN Energy
BYD (1211 HK): Sales Volume Slowing Down in 2Q25, But Competitors Facing Cash Flow Stress
Top Unpaywalled Insights
More »
Reimagining Venture Capital Through Impact Investing | Chris Maher on Disability Innovation
[IO Technicals 2025/28] Bullish Momentum Intensifies
Mid-Year Themes Review - Part II
De-Dollarisation Debate : Unmasking USD Over-Valuation
US Equities Hit All-Time Highs—but Are Markets Ignoring Growing Risks?
Discussions
(Paid Plans Only)
Price Chart
(Sign Up to Access)
Insight Stream
Akeso (康方生物) Placement - Prepping for Commercialization
06 Jan 2021
Akesobio (康方生物) IPO Trading: Action Post Near Zero Allocation
23 Apr 2020
Akesobio (康方生物) IPO: Expect near Zero Allocation
14 Apr 2020
Akesobio (康方生物) Pre-IPO: Clinical Trial Updates from PHIP
08 Apr 2020
Akesobio (康方生物) Pre-IPO: Thoughts on Valuation
10 Mar 2020
Top
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.10
x